- Home
- EDSA vs AIMD Comparison
EDSA vs AIMD Comparison
Compare EDSA & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- AIMD
- Stock Information
- Founded
- EDSA 2015
- AIMD 1984
- Country
- EDSA Canada
- AIMD United States
- Employees
- EDSA N/A
- AIMD N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- EDSA Health Care
- AIMD Health Care
- Exchange
- EDSA Nasdaq
- AIMD Nasdaq
- Market Cap
- EDSA 13.8M
- AIMD 11.9M
- IPO Year
- EDSA N/A
- AIMD N/A
- Fundamental
- Price
- EDSA $2.18
- AIMD $2.86
- Analyst Decision
- EDSA Strong Buy
- AIMD
- Analyst Count
- EDSA 2
- AIMD 0
- Target Price
- EDSA $13.00
- AIMD N/A
- AVG Volume (30 Days)
- EDSA 22.9K
- AIMD 75.3K
- Earning Date
- EDSA 08-08-2025
- AIMD 08-04-2025
- Dividend Yield
- EDSA N/A
- AIMD N/A
- EPS Growth
- EDSA N/A
- AIMD N/A
- EPS
- EDSA N/A
- AIMD N/A
- Revenue
- EDSA N/A
- AIMD $106,207.00
- Revenue This Year
- EDSA N/A
- AIMD N/A
- Revenue Next Year
- EDSA N/A
- AIMD N/A
- P/E Ratio
- EDSA N/A
- AIMD N/A
- Revenue Growth
- EDSA N/A
- AIMD 13.38
- 52 Week Low
- EDSA $1.55
- AIMD $2.00
- 52 Week High
- EDSA $5.59
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- EDSA 60.86
- AIMD 48.86
- Support Level
- EDSA $1.89
- AIMD $3.07
- Resistance Level
- EDSA $2.23
- AIMD $3.34
- Average True Range (ATR)
- EDSA 0.11
- AIMD 0.24
- MACD
- EDSA 0.02
- AIMD 0.01
- Stochastic Oscillator
- EDSA 85.29
- AIMD 54.84
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.